NCT03623698View on ClinicalTrials.gov

Nebulised Hypertonic Saline in Children and Young People With Neuromuscular Disease and Cerebral Palsy

CompletedOBSERVATIONAL
Enrollment

24

Participants

Timeline

Start Date

June 15, 2018

Primary Completion Date

August 14, 2019

Study Completion Date

September 26, 2019

Conditions
Neuromuscular Diseases
Interventions
DRUG

Nebulised hypertonic saline

Nebulised hypertonic saline used for a period of at least 12 months

Trial Locations (1)

SW36NP

Royal Brompton Hospital, London

All Listed Sponsors
collaborator

Royal Brompton & Harefield NHS Foundation Trust

OTHER

lead

Imperial College London

OTHER

NCT03623698 - Nebulised Hypertonic Saline in Children and Young People With Neuromuscular Disease and Cerebral Palsy | Biotech Hunter | Biotech Hunter